Found: 21
Select item for more details and to access through your institution.
Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39383-8
- By:
- Publication type:
- Article
HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Hétérogénéité tumorale des cancers du sein.
- Published in:
- Annales de Biologie Clinique, 2016, v. 74, n. 6, p. 653, doi. 10.1684/abc.2016.1192
- By:
- Publication type:
- Article
Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.1105587
- By:
- Publication type:
- Article
Pattern of relapse in low-risk breast cancer patients followed within a community care network.
- Published in:
- Breast Journal, 2017, v. 23, n. 6, p. 687, doi. 10.1111/tbj.12821
- By:
- Publication type:
- Article
Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research.
- Published in:
- Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-02073-0
- By:
- Publication type:
- Article
Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-86816-9
- By:
- Publication type:
- Article
Author Correction: Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45974-w
- By:
- Publication type:
- Article
Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna<sup>®</sup> Test in the management of early-stage breast cancers.
- Published in:
- PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0185753
- By:
- Publication type:
- Article
Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG Network.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 354, doi. 10.3390/cancers14020354
- By:
- Publication type:
- Article
Febrile neutropenia in adjuvant and neoadjuvant chemotherapy for breast cancer: a retrospective study in routine clinical practice from a single institution.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00319-4
- By:
- Publication type:
- Article
Safety of bevacizumab in clinical practice for recurrent ovarian cancer: A retrospective cohort study.
- Published in:
- Oncology Letters, 2016, v. 11, n. 3, p. 1859, doi. 10.3892/ol.2016.4146
- By:
- Publication type:
- Article
Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 365, doi. 10.1093/neuonc/noac180
- By:
- Publication type:
- Article
VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy—A Message from COMET, a French Unicancer Multicentric Study.
- Published in:
- Pharmaceuticals (14248247), 2020, v. 13, n. 11, p. 414, doi. 10.3390/ph13110414
- By:
- Publication type:
- Article
Disentangling the reasons why older adults do not readily participate in cancer trials: a socio-epidemiological mixed methods approach.
- Published in:
- Age & Ageing, 2024, v. 53, n. 2, p. 1, doi. 10.1093/ageing/afae007
- By:
- Publication type:
- Article